Table 3

Intensity of pain as measured by the Faces pain scale after cannulation at the antecubital fossa for DPL versus placebo

Faces score, median (range)Differences between treatments
Study groupLignocaineShamMedian (95% CI)Significance
A2 (0–4)1 (0–6)0 (−2 to 2)0.77
B0.5 (0–3)1.5 (1–6)−1 (−4 to 0)0.048
C1 (0–3)2 (1–4)−1 (−2 to 0)0.12
D0 (0–6)3 (1–6)−2.5 (−5 to 0)0.019